Spruce Biosciences, Inc. SEC filings SPRB
Spruce Biosciences, Inc. has 366 filings in SEC EDGAR's recent list, going back to Feb 28, 2020. Its latest annual report, Form ARS, was filed on Apr 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 12, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Aug 12, 2026 | Aug 12, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 27, 2026 | Jul 27, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 26, 2026 | May 21, 2026 |
| 8-K |
Current report
Results of operations
|
May 13, 2026 | May 13, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Apr 22, 2026 | Apr 20, 2026 |
| 8-K |
Current report
Agreement ended
|
Mar 20, 2026 | Mar 16, 2026 |
| 8-K |
Current report
Material agreement, Agreement ended, Results of operations, Officer or director change
|
Mar 9, 2026 | Mar 9, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 5, 2026 | Feb 5, 2026 |
| 8-K |
Current report
Material agreement, Results of operations, New debt, Unregistered share sale, Regulation FD disclosure
|
Jan 8, 2026 | Jan 7, 2026 |
| 8-K |
Current report
Officer or director change
|
Dec 15, 2025 | Dec 11, 2025 |
| 8-K |
Current report
Officer or director change
|
Dec 12, 2025 | Dec 11, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2025 | Nov 10, 2025 |
| 8-K |
Current report
Officer or director change
|
Oct 17, 2025 | Oct 15, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Oct 8, 2025 | Oct 7, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2025 | Aug 14, 2025 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure
|
Jul 24, 2025 | Jul 22, 2025 |
| 8-K |
Current report
Listing notice, Other events
|
Jun 12, 2025 | Jun 9, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Other events
|
May 29, 2025 | May 28, 2025 |
| 8-K |
Current report
Results of operations
|
May 6, 2025 | May 6, 2025 |
| 8-K |
Current report
Exit or restructuring costs, Listing notice
|
Apr 25, 2025 | Apr 21, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Apr 15, 2025 | Apr 15, 2025 |
| 8-K |
Current report
Results of operations
|
Apr 1, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Officer or director change
|
Dec 27, 2024 | Dec 20, 2024 |
| 8-K |
Current report
Other events
|
Dec 10, 2024 | Dec 10, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 11, 2024 |
| 8-K |
Current report
Listing notice
|
Oct 28, 2024 | Oct 24, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2024 | Aug 12, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Jun 18, 2024 | Jun 13, 2024 |
| 8-K |
Current report
Other events
|
Jun 3, 2024 | Jun 2, 2024 |
| 8-K |
Current report
Shareholder vote results
|
May 24, 2024 | May 22, 2024 |
| 8-K |
Current report
Results of operations
|
May 13, 2024 | May 13, 2024 |
| 8-K |
Current report
Listing notice
|
Apr 30, 2024 | Apr 26, 2024 |
| 8-K |
Current report
Results of operations, Exit or restructuring costs, Other events
|
Mar 13, 2024 | Mar 10, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jan 8, 2024 | Jan 4, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2023 | Nov 13, 2023 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 14, 2023 | Aug 14, 2023 |
| 8-K |
Current report
Shareholder vote results
|
May 26, 2023 | May 25, 2023 |
| 8-K |
Current report
Officer or director change
|
May 25, 2023 | May 22, 2023 |
| 8-K |
Current report
Results of operations
|
May 15, 2023 | May 15, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 16, 2023 | Mar 16, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Feb 9, 2023 | Feb 8, 2023 |
| 8-K |
Current report
Material agreement, Results of operations, Other events
|
Jan 9, 2023 | Jan 5, 2023 |
| 8-K |
Current report
Material agreement, Agreement ended
|
Dec 2, 2022 | Nov 28, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2022 | Nov 10, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2022 | Aug 10, 2022 |
| 8-K |
Current report
Shareholder vote results
|
May 27, 2022 | May 25, 2022 |
| 8-K |
Current report
Results of operations
|
May 11, 2022 | May 11, 2022 |
| 8-K |
Current report
Officer or director change
|
Apr 8, 2022 | Apr 6, 2022 |
| 8-K |
Current report
Other events
|
Mar 14, 2022 | Mar 14, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 14, 2022 | Mar 14, 2022 |
| 8-K |
Current report
Results of operations, Officer or director change, Other events
|
Jan 5, 2022 | Dec 29, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 15, 2021 | Nov 15, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 15, 2021 | Sep 15, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 25, 2021 | Aug 25, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2021 | Aug 10, 2021 |
| 8-K |
Current report
Officer or director change
|
Jun 29, 2021 | Jun 23, 2021 |
| 8-K |
Current report
Shareholder vote results
|
May 24, 2021 | May 20, 2021 |
| 8-K |
Current report
Results of operations
|
May 12, 2021 | May 12, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 22, 2021 | Mar 22, 2021 |
| 8-K |
Current report
Officer or director change
|
Feb 25, 2021 | Feb 19, 2021 |
| 8-K |
Current report
Results of operations
|
Jan 6, 2021 | Jan 6, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 18, 2020 | Nov 18, 2020 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Oct 14, 2020 | Oct 14, 2020 |
Showing 63 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SPRB (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- South San Francisco, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1683553
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.